Ultragenyx (US-NYSE: RARE) Share Price & Market Data | Grafa

Skip to main content

Hub
News
Signals
Assets
Assets
Market
Country
Economy
Learn
Channel
Author
Company
Grafa TV
Quote
Forex
Quote
Settings

Asset
Signals

Home
quote
Us Nyse
rare

Explore markets

Markets
Financial News
Signals

Get Grafa

Download App
Subscription Plans

Transparency

Publishing Principles
Corrections
Ownership & Funding

Legal & info

T&Cs
Privacy Policy
Cookie Policy
Site Map
About

Get in touch

Contact
Support
Editorial
Advertising

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.

Asset
Signals

Hub
News
Signals
Market
Search

Continue with Grafa

Latest news about RARE

Ultragenyx setrusumab misses primary endpoints in Phase 3 osteogenesis imperfecta trials

Ultragenyx (US-NYSE: RARE) Share Price & Market Data | Grafa